Treating autism pharmacologically: Also tacrine might improve symptomatology in some cases [1]

Journal of Child Neurology

Volumn 22, Issue 8, 2007, Pages 1054-

  Niederhofer, Helmut ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TACRINE;

ADOLESCENT; ADULT; AUTISM; BEHAVIOR DISORDER; CASE REPORT; CLINICAL TRIAL; DRUG INDUCED HEADACHE; HUMAN; HYPERACTIVITY; IRRITABILITY; LANGUAGE DISABILITY; LETTER; OUTCOME ASSESSMENT; PARENTAL ATTITUDE; PATIENT SELECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH PAIN; SYMPTOMATOLOGY; TEACHER;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BRAIN CHEMISTRY; CHOLINESTERASE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; LIVER; MEMANTINE; TACRINE; TREATMENT FAILURE;

EID: 34548154296     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807305857     Document Type: Letter

References (3)

1. Chez MG, Aimonovitch M., Buchanan T., Mrazek S., Tremb RJ Treating autistic spectrum disorders in children: Utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol. 2004;19:165-169.
2. Hertzmann M. Galantamine in the treatment of adult autism: A report of three clinical cases. Int J Psychiatry Med. 2003;33:395-398.
3. Aman MG, Singh NN, Stewart AW, Field CL The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Def. 1985;39:485-491.